Emily Mullin

Emily Mullin is a journalist specializing in biotechnology. She has held positions at MIT Technology Review as an associate editor and at Medium's OneZero as a staff writer covering biotechnology. Her work has also appeared in National Geographic, Scientific American, Smithsonian Magazine, and The Washington Post. Mullin holds a master's degree in science writing from Johns Hopkins University.

81%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

90%

Examples:

  • The articles show a slight tendency to present Neuralink's work in a positive light, particularly regarding its potential for helping paralyzed individuals.
  • The author mentions that Neuralink was founded by Elon Musk without providing any critical analysis of the potential conflicts of interest this might pose.

Conflicts of Interest

75%

Examples:

  • The author mentions that Neuralink was founded by Elon Musk, who is also known for his involvement in other high-profile companies like Tesla and SpaceX. However, no further analysis of potential conflicts of interest is provided.

Contradictions

86%

Examples:

  • The article states that Neuralink's brain implant has faced issues with dislodged threads in one instance, while also presenting a video demonstration of the implant successfully controlling a cursor.
  • The author reports that Elon Musk stated on social media that the first human subject had received Neuralink's implant and was recovering well, contradicting Noland Arbaugh's statement in the same article.

Deceptions

75%

Examples:

  • The article claims that Neuralink's brain-computer interface (BCI) system can decode movement intention from brain signals and allow paralyzed people to control a cursor or keyboard using just their thoughts. This statement implies that the BCI is solely for such purposes, while Neuralink's initial goal is to enable paralyzed individuals to communicate through text messages.
  • The author states that Arbaugh has recovered from his diving accident and can control a computer mouse with his thoughts, when in fact, he is still paralyzed and recovering.

Recent Articles

Elon Musk's Neuralink Chooses Arizona Institute for Groundbreaking Brain-Computer Interface Study with First Participant Noah Arbaugh

Elon Musk's Neuralink Chooses Arizona Institute for Groundbreaking Brain-Computer Interface Study with First Participant Noah Arbaugh

Broke On: Thursday, 18 April 2024 Elon Musk's Neuralink, a brain-implant company, began its Telepathy device study at Barrow Neurological Institute in Phoenix with the first participant, Noah Arbaugh, undergoing a successful procedure. The goal is to enable paralyzed individuals to use computers with their thoughts. Criticized for lack of peer-reviewed research and transparency, the trial evaluates safety and effectiveness of the device on adults with quadriplegia or ALS.
Neuralink's Human Patient Plays Civilization VI for 8 Hours with Thought Control in First Video Demo

Neuralink's Human Patient Plays Civilization VI for 8 Hours with Thought Control in First Video Demo

Broke On: Thursday, 21 March 2024 Neuralink, founded by Elon Musk, released a video of its human patient playing chess using their brain-computer interface device. Noland Arbaugh, a 29-year-old quadriplegic man was able to control the computer mouse with his thoughts and played Civilization VI for eight hours straight during the livestream on Musk's social media platform X.